Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYInterventional Oncology Market Worth $1.5 Billion by 2025, Growing at a CAGR of 7.7% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®PREV STORYUltragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita® (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO)
